163 related articles for article (PubMed ID: 18622681)
1. Pharmacokinetics of repeated dosing of linezolid in a hemodialysis patient with chronic renal failure.
Tsuji Y; Hiraki Y; Mizoguchi A; Hayashi W; Kamohara R; Kamimura H; Karube Y
J Infect Chemother; 2008 Apr; 14(2):156-60. PubMed ID: 18622681
[TBL] [Abstract][Full Text] [Related]
2. Thrombocytopenia and anemia caused by a persistent high linezolid concentration in patients with renal dysfunction.
Tsuji Y; Hiraki Y; Matsumoto K; Mizoguchi A; Kobayashi T; Sadoh S; Morita K; Kamimura H; Karube Y
J Infect Chemother; 2011 Feb; 17(1):70-5. PubMed ID: 20582446
[TBL] [Abstract][Full Text] [Related]
3. Single-dose linezolid pharmacokinetics in critically ill patients with impaired renal function especially chronic hemodialysis patients.
El-Assal MI; Helmy SA
Biopharm Drug Dispos; 2014 Oct; 35(7):405-16. PubMed ID: 25044219
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and elimination efficiency of linezolid during dialysis.
Hiraki Y; Tsuji Y; Misumi N; Hiraike M; Matsumoto K; Morita K; Kamimura H; Karube Y
Ren Fail; 2013; 35(3):418-20. PubMed ID: 23356475
[TBL] [Abstract][Full Text] [Related]
5. Influence of linezolid clearance on the induction of thrombocytopenia and reduction of hemoglobin.
Hiraki Y; Tsuji Y; Matsumoto K; Morita K; Kamimura H; Karube Y
Am J Med Sci; 2011 Dec; 342(6):456-60. PubMed ID: 21681075
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of intravitreal administrations of linezolid in an experimental model of S. aureus-related endophthalmitis.
Saleh M; Lefèvre S; Acar N; Bourcier T; Marcellin L; Prévost G; Subilia A; Gaucher D; Jehl F
Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):4832-41. PubMed ID: 22661478
[TBL] [Abstract][Full Text] [Related]
7. Plasma exposure of free linezolid and its ratio to minimum inhibitory concentration varies in critically ill patients.
Yagi T; Naito T; Doi M; Nagura O; Yamada T; Maekawa M; Sato S; Kawakami J
Int J Antimicrob Agents; 2013 Oct; 42(4):329-34. PubMed ID: 23988716
[TBL] [Abstract][Full Text] [Related]
8. Effect of linezolid against postneurosurgical meningitis caused by methicillin-resistant Staphylococcus epidermidis: case report.
Nagashima G; Okamoto N; Okuda M; Nakashima K; Noda M; Itokawa H; Suzuki R; Fujimoto T; Marumo K
J Infect Chemother; 2008 Apr; 14(2):147-50. PubMed ID: 18622679
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of linezolid in septic patients with and without extended dialysis.
Swoboda S; Ober MC; Lichtenstern C; Saleh S; Schwenger V; Sonntag HG; Haefeli WE; Hempel G; Hoppe-Tichy T; Weigand MA
Eur J Clin Pharmacol; 2010 Mar; 66(3):291-8. PubMed ID: 20013257
[TBL] [Abstract][Full Text] [Related]
10. Higher linezolid exposure and higher frequency of thrombocytopenia in patients with renal dysfunction.
Matsumoto K; Takeshita A; Ikawa K; Shigemi A; Yaji K; Shimodozono Y; Morikawa N; Takeda Y; Yamada K
Int J Antimicrob Agents; 2010 Aug; 36(2):179-81. PubMed ID: 20392606
[TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo assessment of linezolid combined with ertapenem: a highly synergistic combination against methicillin-resistant Staphylococcus aureus.
Jacqueline C; Caillon J; Grossi O; Le Mabecque V; Miegeville AF; Bugnon D; Batard E; Potel G
Antimicrob Agents Chemother; 2006 Jul; 50(7):2547-9. PubMed ID: 16801442
[TBL] [Abstract][Full Text] [Related]
12. Linezolid treatment for intracranial abscesses caused by methicillin-resistant Staphylococcus aureus--two case reports.
Saito N; Aoki K; Sakurai T; Ito K; Hayashi M; Hirata Y; Sato K; Harashina J; Akahata M; Iwabuchi S
Neurol Med Chir (Tokyo); 2010; 50(6):515-7. PubMed ID: 20587984
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of intravenous and oral linezolid in adults with cystic fibrosis.
Keel RA; Schaeftlein A; Kloft C; Pope JS; Knauft RF; Muhlebach M; Nicolau DP; Kuti JL
Antimicrob Agents Chemother; 2011 Jul; 55(7):3393-8. PubMed ID: 21518837
[TBL] [Abstract][Full Text] [Related]
14. EUCAST Technical Note on linezolid.
European Committee on Antimicrobial Susceptibility Testing (EUCAST) Steering Committee
Clin Microbiol Infect; 2006 Dec; 12(12):1243-5. PubMed ID: 17121637
[No Abstract] [Full Text] [Related]
15. Does haemodialysis significantly affect serum linezolid concentrations in critically ill patients with renal failure? A pilot investigation.
Fiaccadori E; Maggiore U; Rotelli C; Giacosa R; Parenti E; Picetti E; Manini P; Andreoli R; Cabassi A
Nephrol Dial Transplant; 2006 May; 21(5):1402-6. PubMed ID: 16504979
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of MRSA native valve endocarditis with oral linezolid therapy: a case report.
Nathani N; Iles P; Elliott TS
J Infect; 2005 Nov; 51(4):e213-5. PubMed ID: 16291272
[TBL] [Abstract][Full Text] [Related]
17. Linezolid-resistant Staphylococcus aureus in two pediatric patients receiving low-dose linezolid therapy.
Roberts SM; Freeman AF; Harrington SM; Holland SM; Murray PR; Zelazny AM
Pediatr Infect Dis J; 2006 Jun; 25(6):562-4. PubMed ID: 16732160
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and tolerance of single- and multiple-dose oral or intravenous linezolid, an oxazolidinone antibiotic, in healthy volunteers.
Stalker DJ; Jungbluth GL; Hopkins NK; Batts DH
J Antimicrob Chemother; 2003 May; 51(5):1239-46. PubMed ID: 12668582
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and tolerance of linezolid for meticillin-resistant Staphylococcus aureus mediastinitis in paediatric patients.
Kosaka T; Kokufu T; Shime N; Sugioka N; Kato R; Hamaoka K; Fujita N
Int J Antimicrob Agents; 2009 Apr; 33(4):368-70. PubMed ID: 19097868
[TBL] [Abstract][Full Text] [Related]
20. Impact of ontogeny on linezolid disposition in neonates and infants.
Kearns GL; Jungbluth GL; Abdel-Rahman SM; Hopkins NK; Welshman IR; Grzebyk RP; Bruss JB; Van Den Anker JN;
Clin Pharmacol Ther; 2003 Nov; 74(5):413-22. PubMed ID: 14586382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
